Literature DB >> 26738993

Integrating Rapid Diagnostics and Antimicrobial Stewardship in Two Community Hospitals Improved Process Measures and Antibiotic Adjustment Time.

Ashley M Lockwood1, Katherine K Perez1, William L Musick1, Judy O Ikwuagwu1, Engie Attia1, Oyejoke O Fasoranti1, Patricia L Cernoch1, Randall J Olsen1, James M Musser1.   

Abstract

OBJECTIVE To assess the impact of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry for rapid pathogen identification directly from early-positive blood cultures coupled with an antimicrobial stewardship program (ASP) in two community hospitals. Process measures and outcomes prior and after implementation of MALDI-TOF/ASP were evaluated. DESIGN Multicenter retrospective study. SETTING Two community hospitals in a system setting, Houston Methodist (HM) Sugar Land Hospital (235 beds) or HM Willowbrook Hospital (241 beds). PATIENTS Patients ≥ 18 years of age with culture-proven Gram-negative bacteremia. INTERVENTION Blood cultures from both hospitals were sent to and processed at our central microbiology laboratory. Clinical pharmacists at respective hospitals were notified of pathogen ID and susceptibility results. RESULTS We evaluated 572 patients for possible inclusion. After pre-defined exclusion criteria, 151 patients were included in the pre-intervention group and 242 were included in the intervention group. After MALDI-TOF/ASP implementation, the mean identification time after culture positivity was significantly reduced from 32 hours (±16 hours) to 6.5 hours (±5.4 hours) (P<.001); mean time to susceptibility results was significantly reduced from 48 (±22) hours to 23 (±14) hours (P<.001); and time to therapy adjustment was significantly reduced from 75 (±59) hours to 30 (±30) hours (P<.001). Mean hospital costs per patient were $3,411 less in the intervention group compared with the pre-intervention group ($18,645 vs $15,234; P=.04). CONCLUSION This study is the first to analyze the impact of MALDI-TOF coupled with an ASP in a community hospital setting. Time to results significantly differed with the use of MALDI-TOF, and time to appropriate therapy was significantly improved with the addition of ASP.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26738993     DOI: 10.1017/ice.2015.313

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  23 in total

Review 1.  Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship.

Authors:  Philippe Morency-Potvin; David N Schwartz; Robert A Weinstein
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

2.  Blood Culture Turnaround Time in U.S. Acute Care Hospitals and Implications for Laboratory Process Optimization.

Authors:  Ying P Tabak; Latha Vankeepuram; Gang Ye; Kay Jeffers; Vikas Gupta; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

3.  Diagnostic Stewardship: Opportunity for a Laboratory-Infectious Diseases Partnership.

Authors:  Robin Patel; Ferric C Fang
Journal:  Clin Infect Dis       Date:  2018-08-16       Impact factor: 9.079

4.  Impact of a Rapid Blood Culture Diagnostic Test in a Children's Hospital Depends on Gram-Positive versus Gram-Negative Organism and Day versus Night Shift.

Authors:  Lillian J Juttukonda; Sophie Katz; Jessica Gillon; Jonathon Schmitz; Ritu Banerjee
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

Review 5.  The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship.

Authors:  Elina Eleftheria Pliakos; Nikolaos Andreatos; Fadi Shehadeh; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

6.  Commentary: Can Automated Blood Culture Systems Be Both New and Improved?

Authors:  Blake W Buchan
Journal:  J Clin Microbiol       Date:  2022-04-04       Impact factor: 11.677

7.  Diagnosing Emerging Fungal Threats: A One Health Perspective.

Authors:  Pria N Ghosh; Matthew C Fisher; Kieran A Bates
Journal:  Front Genet       Date:  2018-09-11       Impact factor: 4.599

8.  Clinical Impact and Provider Acceptability of Real-Time Antimicrobial Stewardship Decision Support for Rapid Diagnostics in Children With Positive Blood Culture Results.

Authors:  Kevin Messacar; Amanda L Hurst; Jason Child; Kristen Campbell; Claire Palmer; Stacey Hamilton; Elaine Dowell; Christine C Robinson; Sarah K Parker; Samuel R Dominguez
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

9.  Recent Advances and Ongoing Challenges in the Diagnosis of Microbial Infections by MALDI-TOF Mass Spectrometry.

Authors:  Walter Florio; Arianna Tavanti; Simona Barnini; Emilia Ghelardi; Antonella Lupetti
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

10.  Improving American Healthcare Through "Clinical Lab 2.0": A Project Santa Fe Report.

Authors:  James M Crawford; Khosrow Shotorbani; Gaurav Sharma; Michael Crossey; Tarush Kothari; Thomas S Lorey; Jeffrey W Prichard; Myra Wilkerson; Nancy Fisher
Journal:  Acad Pathol       Date:  2017-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.